Calcium antagonists and cancer: limitations of pros and cons.
Hamet
P
P
Centre hospitalier de l'Université de Montréal, Quebec, Canada.
D000368:Aged; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D015331:Cohort Studies; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D009369:Neoplasms / Q000209:etiology*; D011446:Prospective Studies; D012307:Risk Factors; D012449:Safety
D002121:Calcium Channel Blockers